These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 1466270)
1. Inhibition of glandular and plasma kallikrein by benzamidine derivatives. Stürzebecher J; Vieweg H; Prasa D Agents Actions Suppl; 1992; 38 ( Pt 1)():190-7. PubMed ID: 1466270 [TBL] [Abstract][Full Text] [Related]
2. Novel plasma kallikrein inhibitors of the benzamidine type. Stürzebecher J; Prasa D; Wikström P; Vieweg H Braz J Med Biol Res; 1994 Aug; 27(8):1929-34. PubMed ID: 7749383 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of bovine beta-trypsin, human alpha-thrombin and porcine pancreatic beta-kallikrein-B by benzamidine and its bis-, tris- and tetra-derivatives: thermodynamic and molecular modeling study. Menegatti E; Ferroni R; Nastruzzi C; Bortolotti F; Scalia S; Amiconi G; Bolognesi M; Coletta M; Onesti S; Fruttero R Farmaco; 1991 Nov; 46(11):1297-310. PubMed ID: 1811616 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of bovine beta-trypsin, human alpha-thrombin and porcine pancreatic beta-kallikrein-B by 4',6-diamidino-2-phenylindole, 6-amidinoindole and benzamidine: a comparative thermodynamic and X-ray structural study. Casale E; Collyer C; Ascenzi P; Balliano G; Milla P; Viola F; Fasano M; Menegatti E; Bolognesi M Biophys Chem; 1995 Mar; 54(1):75-81. PubMed ID: 7703351 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of human mast cell tryptase by benzamidine derivatives. Stürzebecher J; Prasa D; Sommerhoff CP Biol Chem Hoppe Seyler; 1992 Oct; 373(10):1025-30. PubMed ID: 1418674 [TBL] [Abstract][Full Text] [Related]
6. Novel bis(benzamidino) compounds with an aromatic central link. Inhibitors of thrombin, pancreatic kallikrein, trypsin, and complement. Geratz JD; Cheng MC; Tidwell RR J Med Chem; 1976 May; 19(5):634-9. PubMed ID: 1271404 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of batroxobin, a serine proteinase from Bothrops snake venom, by derivatives of benzamidine. Stürzebecher J; Stürzebecher U; Markwardt F Toxicon; 1986; 24(6):585-95. PubMed ID: 3529503 [TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships for the inhibition of acrosin by benzamidine derivatives. Parrish RF; Straus JW; Paulson JD; Polakoski KL; Tidwell RR; Geratz JD; Stevens FM J Med Chem; 1978 Nov; 21(11):1132-6. PubMed ID: 722718 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of serine proteinases by benzamidine derivatives. Walsmann P Acta Biol Med Ger; 1977; 36(11-12):1931-7. PubMed ID: 616739 [TBL] [Abstract][Full Text] [Related]
10. Design of novel cationic ligands for the purification of trypsin-like proteases by affinity chromatography. Burton NP; Lowe CR J Mol Recognit; 1993 Mar; 6(1):31-40. PubMed ID: 8251190 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of activated protein C by benzamidine derivatives. Stürzebecher J; Prasa D; Taby O Thromb Res; 1993 Mar; 69(6):533-9. PubMed ID: 8503121 [TBL] [Abstract][Full Text] [Related]
12. New aromatic diamidines with central alpha-oxyalkane or alpha, omega-dioxyalkane chains. Structure-activity relationships for the inhibition of trypsin, pancreatic kallikrein, and thrombin and for the inhibition of the overall coagulation process. Geratz JD; Cheng MC; Tidwell RR J Med Chem; 1975 May; 18(5):477-81. PubMed ID: 1171238 [TBL] [Abstract][Full Text] [Related]
13. Linear competitive inhibition of human tissue kallikrein by 4-aminobenzamidine and benzamidine and linear mixed inhibition by 4-nitroaniline and aniline. Sousa MO; Miranda TL; Costa EB; Bittar ER; Santoro MM; Figueiredo AF Braz J Med Biol Res; 2001 Jan; 34(1):35-44. PubMed ID: 11151026 [TBL] [Abstract][Full Text] [Related]
14. Design and development of a series of borocycles as selective, covalent kallikrein 5 inhibitors. Walker AL; Denis A; Bingham RP; Bouillot A; Edgar EV; Ferrie A; Holmes DS; Laroze A; Liddle J; Fouchet MH; Moquette A; Nassau P; Pearce AC; Polyakova O; Smith KJ; Thomas P; Thorpe JH; Trottet L; Wang Y; Hovnanian A Bioorg Med Chem Lett; 2019 Oct; 29(20):126675. PubMed ID: 31521475 [TBL] [Abstract][Full Text] [Related]
15. Active site mapping of trypsin, thrombin and matriptase-2 by sulfamoyl benzamidines. Dosa S; Stirnberg M; Lülsdorff V; Häußler D; Maurer E; Gütschow M Bioorg Med Chem; 2012 Nov; 20(21):6489-505. PubMed ID: 23026080 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of porcine glandular kallikreins by structurally homologous proteinase inhibitors of the Kunitz (Trasylol) type. Significance of the basic nature of amino acid residues in subside positions for kallikrein inhibition. Dietl T; Huber C; Geiger R; Iwanaga S; Fritz H Hoppe Seylers Z Physiol Chem; 1979 Jan; 360(1):67-71. PubMed ID: 761847 [TBL] [Abstract][Full Text] [Related]
17. [Synthetic inhibitors of serine proteinases. Part 26: Inhibition of trypsin, plasmin and thrombin by amides of N alpha-arylsulfonylated 2-amino-4-(4-amidino-phenyl) butyric acid and 2-amino-5-amidinophenyl valeric acids (author's transl)]. Stürzebecher J; Markwardt F; Vieweg H; Wagner G; Walsmann P Pharmazie; 1982 Apr; 37(4):281-3. PubMed ID: 6212947 [TBL] [Abstract][Full Text] [Related]
18. [Effectiveness of commercial polyvalent proteinase inhibitors. Comparative analysis of their effect on kallikreins from different sources and trypsin]. Iarovaia GA; Dotsenko VL; Agapova EI; Stepanian EP Vopr Med Khim; 1980; 26(6):832-7. PubMed ID: 6161484 [TBL] [Abstract][Full Text] [Related]